Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis

The American Journal of Medicine
Guillermo E UmpierrezAbbas E Kitabchi

Abstract

To compare the efficacy and safety of subcutaneous insulin lispro with that of a standard low-dose intravenous infusion protocol of regular insulin in patients with uncomplicated diabetic ketoacidosis. In this prospective, randomized open trial, 20 patients treated with subcutaneous insulin lispro were managed in regular medicine wards (n=10) or an intermediate care unit (n=10), while 20 patients treated with the intravenous protocol were managed in the intensive care unit. Patients treated with subcutaneous lispro received an initial injection of 0.3 unit/kg followed by 0.1 unit/kg/h until correction of hyperglycemia (blood glucose levels <250 mg/dL), followed by 0.05 to 0.1 unit/kg/h until resolution of diabetic ketoacidosis (pH > or =7.3, bicarbonate > or =18 mEq/L). Patients treated with intravenous regular insulin received an initial bolus of 0.1 unit/kg, followed by an infusion of 0.1 unit/kg/h until correction of hyperglycemia, then 0.05 to 0.1 unit/kg/h until resolution of diabetic ketoacidosis. Mean (+/- SD) admission biochemical parameters in patients treated with subcutaneous lispro (glucose: 674 +/- 154 mg/dL; bicarbonate: 9.2 +/- 4 mEq/L; pH: 7.17 +/- 0.10) were similar to values in patients treated with intravenou...Continue Reading

References

Aug 4, 1977·The New England Journal of Medicine·J N FisherA E Kitabchi
Sep 17, 1977·British Medical Journal·D Leslie, P M Coats
Oct 1, 1977·La Nouvelle presse médicale·J MirouzeJ L Selam
Oct 1, 1977·Archives of Internal Medicine·K G Alberti
May 1, 1976·The Journal of Clinical Endocrinology and Metabolism·S M Guerra, A E Kitabchi
Nov 1, 1987·Diabetes Care·J M GuerinJ M Segrestaa
May 5, 1973·Lancet·N G SolerJ M Malins
Mar 19, 1973·JAMA : the Journal of the American Medical Association·S M Genuth
Jun 29, 1974·British Medical Journal·M M PageT E West
Nov 1, 1993·The American Journal of the Medical Sciences·M E MayJ King
May 1, 1996·The American Journal of the Medical Sciences·G E UmpierrezA E Kitabchi
Oct 25, 1996·The Medical Letter on Drugs and Therapeutics
Mar 24, 1997·Archives of Internal Medicine·G E UmpierrezA E Kitabchi
Jul 17, 1997·The New England Journal of Medicine·F Holleman, J B Hoekstra
Nov 5, 1999·Archives of Internal Medicine·A BalasubramanyamV Pavlik
Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·M F DelaneyW M Kettyle
Feb 24, 2001·Diabetes Care·A E KitabchiB M Wall
Dec 26, 2002·Journal of Critical Care·Amado X FreireAbbas E Kitabchi

❮ Previous
Next ❯

Citations

Nov 2, 2012·Current Diabetes Reports·Devin W SteenkampMarie E McDonnell
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Arlan L Rosenbloom
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Becky ArmorFrank Lawler
Dec 18, 2013·British Journal of Anaesthesia·J J SebranekD B Coursin
Jul 22, 2006·American Journal of Therapeutics·Afshin Salsali, Muriel Nathan
Mar 18, 2008·Journal of Nursing Care Quality·Ruth Ferreri
Jan 8, 2009·American Journal of Therapeutics·Paul Bradley, Joseph D Tobias
Jun 17, 2010·Diabetology & Metabolic Syndrome·Roberta D SavoldelliThais D Manna
Feb 14, 2008·The Journal of Clinical Endocrinology and Metabolism·Abbas E KitabchiFrankie B Stentz
Jul 2, 2008·Paediatric Drugs·Nicole A Sherry, Lynne L Levitsky
Aug 17, 2011·Indian Journal of Pharmacology·R KaroliR Shankar
Dec 4, 2010·Indian Journal of Pediatrics·Sindhu SivanandanRakesh Lodha
May 17, 2006·The American Journal of the Medical Sciences·Mohsen S EledrisiNermeen Jaha
Jan 20, 2016·Diabetes Technology & Therapeutics·Jagdeesh UllalJoseph Aloi
Mar 16, 2016·Metabolism: Clinical and Experimental·Ebenezer A Nyenwe, Abbas E Kitabchi
Apr 29, 2014·Emergency Medicine Clinics of North America·Brian CorwellGeorge C Willis
Feb 26, 2016·Diabetes Care·Guillermo E Umpierrez
May 16, 2014·Canadian Journal of Diabetes·Jeannette GoguenJeremy Gilbert
Sep 18, 2015·Journal of Veterinary Emergency and Critical Care·Eric S WalshRebecka S Hess
Jun 15, 2011·The American Journal of Emergency Medicine·Oscar M P Jolobe
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Feb 20, 2016·Nature Reviews. Endocrinology·Guillermo Umpierrez, Mary Korytkowski
Dec 16, 2005·Pediatric Annals·John M OberlinCydney L Fenton
Nov 28, 2006·Endocrinology and Metabolism Clinics of North America·Abbas E Kitabchi, Ebenezer A Nyenwe
Nov 28, 2006·Diabetes Research and Clinical Practice·Otto M HenriksenOle Lander Svendsen
Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·R WenzelJ A Borrego
Feb 10, 2006·Pharmacotherapy·Kevin E Anger, Paul M Szumita
Oct 8, 2011·Diabetes Research and Clinical Practice·Ebenezer A Nyenwe, Abbas E Kitabchi
Jan 11, 2005·The American Journal of Medicine·Leszek CzupryniakJerzy Loba
Jul 27, 2015·Clinical Therapeutics·Brenna L BradySusan C Bolge
Jul 1, 2009·Diabetes Care·Abbas E KitabchiJoseph N Fisher
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association
Sep 1, 2004·The American Journal of Medicine·Romana M Haas, Andrew R Hoffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.